Fintan R. Steele

Fintan Steele returned to the Broad Institute in 2008 as the Director of Communications, working the previous two years as Executive Vice President of the Life Sciences group for Feinstein Kean Healthcare where he worked with a variety of private and public clients in the molecular medicine field. Although he enjoyed his experience at Feinstein Kean Healthcare, he believes that "ultimately there is no place like the Broad Institute."

Fintan's background includes 16 years of experience in communicating the science and implications of genetics and genomics to a variety of audiences. Prior to his first tenure at Broad he was the Global Head of Communications for the Novartis Institutes for BioMedical Research. He also held several editorial positions for public and private scientific publishers, including News and News & Views editor for Nature Medicine, Executive Editor of the Journal of Clinical Investigation, and Executive Editor of Genomics and of Molecular Therapy.

After receiving his doctorate from the University of Notre Dame in South Bend, Ind., Fintan completed postdoctoral fellowships at the National Eye Institute, National Institutes of Health and at Johns Hopkins School of Medicine. He also holds a Masters of Divinity degree from St. Meinrad School of Theology as well as a Masters of Arts in Medical Ethics/Religious Studies from Indiana University, where he focused on ethical issues in genetic engineering.